The business rates bust-up as retailers hand back cash
Supermarkets and other stores that had come under fire for accepting a business-rates holiday have given the money back. Matthew Partridge reports
Until last week UK supermarkets had behaved like “brothers in arms”, says Sam Chambers in The Sunday Times. They “uniformly” rebuffed calls to return the “contentious £2bn-plus tax windfall” that they had received from the Treasury’s 12-month business rates holiday, “despite continuing to pay dividends”. However, last week Tesco declared that it would return the £585m it had been given. This triggered a “domino effect”, with Morrisons, Sainsbury’s, and B&M following suit.
Despite most of the supermarkets now pretending that they have been considering returning the cash “for some time”, it was only Tesco’s action that forced their hand, says Ben Marlow in The Daily Telegraph. Even Tesco doesn’t really deserve any praise since its decision came as a result of a “fierce and sustained” public backlash.
Of course, the supermarkets maintain that “massive uncertainty” combined with the fact that they were open during the pandemic in “difficult circumstances” justified the subsidy. However, the tax break was clearly intended for retailers and firms forced to close their doors.
Subscribe to MoneyWeek
Subscribe to MoneyWeek today and get your first six magazine issues absolutely FREE
Sign up to Money Morning
Don't miss the latest investment and personal finances news, market analysis, plus money-saving tips with our free twice-daily newsletter
Don't miss the latest investment and personal finances news, market analysis, plus money-saving tips with our free twice-daily newsletter
An essential furniture and toys retailer
Probably the most “gratuitously undeserved” handout, however, went to B&M, says Nils Pratley in The Guardian. It sells some food, so it qualified as an “essential retailer” and stayed open, but its shelves are mostly filled with “toys, games, furniture, stationery and rugs”. With most of its non-food competitors “ruled offside”, B&M had the “freedom of the inessential pitch”, so it reported “a 30% improvement in like-for-like sales in a six-month period” and a “near-doubling of top-line profits to £296m”. The decision to give B&M £38m of relief on rates looks “obscene”.
As for Tesco, its decision to break ranks wasn’t as generous as it might appear, says Bryce Elder in the Financial Times. While Tesco received the most in absolute terms, the support mattered more to J Sainsbury, whose Argos chain was classed as non-essential. The amount that Sainsbury has had to return “equates to nearly 10% of its market value, versus less than 3% for Tesco”. A cynic might conclude that Tesco’s motivations “have an element of game theory”, in that it has “invited mutual harm from which it expects to suffer the least”.
Meanwhile, you can see why John Lewis, which owns Waitrose, is “breaking with the supermarket pack to cling to tens of millions of pounds of pandemic tax relief”, says Christopher Williams in The Sunday Telegraph.
Under “massive financial pressure”, the group has borrowed £300m from the Bank of England’s emergency loans scheme, taken out £150m in new bank loans and sold Waitrose property for £135m. John Lewis’ financial problems underline the fact that the post-pandemic high street “will be a... poorer and less diverse place”.
Matthew graduated from the University of Durham in 2004; he then gained an MSc, followed by a PhD at the London School of Economics.
He has previously written for a wide range of publications, including the Guardian and the Economist, and also helped to run a newsletter on terrorism. He has spent time at Lehman Brothers, Citigroup and the consultancy Lombard Street Research.
Matthew is the author of Superinvestors: Lessons from the greatest investors in history, published by Harriman House, which has been translated into several languages. His second book, Investing Explained: The Accessible Guide to Building an Investment Portfolio, is published by Kogan Page.
As senior writer, he writes the shares and politics & economics pages, as well as weekly Blowing It and Great Frauds in History columns He also writes a fortnightly reviews page and trading tips, as well as regular cover stories and multi-page investment focus features.
Follow Matthew on Twitter: @DrMatthewPartri
-
Barclays bank caps in-branch cash deposits for personal banking customers
News Barclays has placed a cap on how much you can pay into your bank with cash in a bid to fight financial crime - will you be affected?
By Henry Sandercock Published
-
State pension warning as families opting out of child benefit hits record high
Up to one million parents could be losing out on £6,500 in retirement because they have opted out of receiving child benefit.
By Ruth Emery Published
-
The industry at the heart of global technology
The semiconductor industry powers key trends such as artificial intelligence, says Rupert Hargreaves
By Rupert Hargreaves Published
-
Three emerging Asian markets to invest in
Professional investor Chetan Sehgal of Templeton Emerging Markets Investment Trust tells us where he’d put his money
By Chetan Sehgal Published
-
What to consider before investing in small-cap indexes
Small-cap index trackers show why your choice of benchmark can make a large difference to long-term returns
By Cris Sholto Heaton Published
-
Why space investments are the way to go for investors
Space investments will change our world beyond recognition, UK investors should take note
By Merryn Somerset Webb Published
-
Time to tap into Africa’s mobile money boom
Favourable demographics have put Africa on the path to growth when it comes to mobile money and digital banking
By Rupert Hargreaves Published
-
M&S is back in fashion: but how long can this success last?
M&S has exceeded expectations in the past few years, but can it keep up the momentum?
By Rupert Hargreaves Published
-
The end of China’s boom
Like the US, China too got fat on fake money. Now, China's doom is not far away.
By Bill Bonner Published
-
Magic mushrooms — an investment boom or doom?
Investing in these promising medical developments might see you embark on the trip of a lifetime.
By Bruce Packard Published